M-VENLAFAXINE XR

mantra pharma inc🇨🇦 Health Canada

Approval Id: 8def6a6938de78a2
Drug Approval Canada Name: M-VENLAFAXINE XR
Product Name: M-VENLAFAXINE XR
Status: Marketed
Status Date: 2018-03-07
Original Market Date: 2018-03-07
Din: 02471280
Drug Class: Human
Dosage Form: Capsule (Extended Release)
Route Of Administration: Oral
Schedule: Prescription
Ahfs: 28:16.04.16
Atc Original: N06AX16 VENLAFAXINE
Atc Name: n 06 ax 16
Aig Number: 0131294002
Company Name: mantra pharma inc
Company Address: 1000 Rue Du Lux Suite 201, Brossard, Quebec, Canada, J4Y 0E3

VENLAFAXINE (VENLAFAXINE HYDROCHLORIDE)

37.5 MG

Authorized

Agency

Health Canada

Country

🇨🇦

Approval Date

Jul 4, 2025

Approval ID

8def6a6938de78a2

Type

Standard